Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Subcutaneous Administration of Anakinra in Patients With CF [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of subcutaneous Anakinra in patients with cystic fibrosis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Anakinra (Kineret) (Anakinra)

Snippet

Sponsor: Heidelberg University | Conditions: Cystic Fibrosis, 10011762 | Phase 2 | Status: RECRUITING